QUEST informs readers of the latest advances in urologic prostate cancer research, especially detection, prevention, and treatment.
Comparing Treatments Radical prostatectomy provides a higher 7-year PSA progression-free rate than other treatments for localized prostate cancer. A member of Dr. Catalona’s research team in St. Louis, Julie Krygiel, reported preliminary results at the American Urological Association (AUA) on…
One Man to Another Statistics and Prognosis Based upon his case history, Jules Reichel discusses the statistics of prostate cancer and how they relate to a patient’s prognosis. A second topic covered is considerations in choosing a doctor for treatment…
At a conference focused on prostate cancer treatments and cures, Dr. Catalona presented findings on recent prostate cancer studies. The following are summaries of those presentations: Age Has Impact on Continence After RRP Dr. Catalona completed a study to look…
Defining a nerve-sparing radical prostatectomy is easy: During the surgical removal of the prostate gland, an attempt is made to spare the two cavernous nerve sheaths (lying slightly underneath and to the sides of the gland) that produce erections. Completing…
This article discusses medical specifications of prostate cancer: clinical stage, PSA reading, DRE findings, number and percentage of cancer in biopsy cores, and Gleason score. It answers the questions: What do I do with these terms of the specification of…
New findings are improving the screening procedures for prostate cancer. This article is based upon a State-of-the-Art Presentation given by Dr. Catalona at the American Urological Association Annual Meeting this May. The genetics revolution will change the way prostate cancer…
Nerve-sparing RRP (radical prostatectomy) can result in preserving potency and continence with a low complication rate. Complications can be reduced with increasing surgeon experience. The June 19 Wall Street Journal contained an article on nerve-sparing radical prostatectomy. Information included six…
This column is the first of a series in which patient and patient advocate Jules Reichel discusses emotions, issues, and facts surrounding the treatment of prostate cancer. Why a patient’s column? This is not a doctor’s column. I am, in…
“The declining mortality rates in the US since the widespread use of PSA testing certainly suggest PSA screening saves lives.” Some material in recent articles suggest that PSA screening finds prostate cancers that are then treated when they don’t need…
“We should be able to cure 90% of prostate cancer with early detection and appropriate treatment recommendations.” The key to good results in treating localized prostate cancer is to make the diagnosis as early as possible. Now, at least 80%…
"*" indicates required fields
